Krystal Biotech, Inc. (KRYS)

Healthcare Model Divergence low healthy

$358.24

Updated: 2026-08-31

TradeApes Score

Financial Strength

86 Strong

Operating Trend

92 Strong

Relative Value

37 Overvalued

Capital Allocation

45 Mixed

Risk Management

76 Strong

Sector Rank #309

The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for KRYS.

Key Findings

+ operating-margin trend + inflection

Unlock Full Report →

− ev_to_ebitda vs sector peers

Unlock Full Report →

Industry Related Stocks

Acumen Pharmaceuticals, Inc. (ABOS) Abpro Holdings, Inc. (ABPO) Abpro Holdings, Inc. (ABPWW) Arcellx, Inc. (ACLX) Alpha Cognition Inc. (ACOG) ADMA BIOLOGICS, INC. (ADMA)

See all Healthcare stocks →

Get KRYS and 3,000+ stocks in your pocket

Health scores, fair-value estimates, and full company analysis — free on iPhone.

Download iPhone App

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.